Drs. Simon Hogan and Nicholas Lukacs Receive Strategic Initiative Fund Award to Establish Michigan Center for Human Immunology Model Systems (Mi-CHIM)

Anew University of Michigan initiative aims to address one of biomedical research’s most persistent challenges: why therapies that succeed in animal models often fail in human patients. Now, a new initiative led by Drs. Simon P. Hogan, the Askwith Research Professor of Food Allergy, Mary H. Weiser Food Allergy Center and Professor of Pathology, and Nicholas W. Lukacs, the Godfrey Dorr Stobbe Professor of Pathology and interim Director of the Mary H. Weiser Food Allergy Center, aims to help close that gap.

Drs. Westerhoff and Kakar Lead New Edition of Diagnostic Pathology: Hepatobiliary and Pancreas

Dr. Maria Westerhoff, alongside Co-Lead Author Dr. Sanjay Kakar of the University of California, San Francisco, has captured the latest advancements in gastrointestinal pathology in the newly published fourth edition of Diagnostic Pathology: Hepatobiliary and Pancreas. Published by Elsevier, the full-color textbook is now available as a comprehensive, expertly curated guide to one of the most challenging areas in pathology.

Cancer Cell Study Identifies Promising New Therapeutic Strategy for Aggressive Neuroendocrine Prostate Cancer

Researchers at the University of Michigan have identified a previously unrecognized survival mechanism in neuroendocrine prostate cancer (NEPC), one of the most aggressive and difficult-to-treat forms of prostate cancer. The findings, which have been published in Cancer Cell, uncover a critical vulnerability in NEPC and suggest a novel dual-targeting strategy that could eventually lead to more effective treatment options for patients with advanced disease.